Deccan Healthcare, an innovative products company in the Indian health and wellness market, has received a Rs 15 crore investment from Nexus Venture Partners.
Deccan Healthcare has developed, through intensive R&D, a variety of nutraceutical products which boost immunity and address chronic ailments. The key products include a flaxseed-based vegetarian Omega-3 which they sell under the OxyFlax and Nulife-ISB brand. It is useful for cardiac care, bone health, diabetes prevention, and is also anti carcinogenic and anti-inflammatory.
Speaking about the funding, Mr Minto Gupta, Founder & CEO, Deccan Healthcare said, “We at Deccan Healthcare are happy to be associated with Nexus Venture Partners. The funding will help us enhance our R&D efforts and our expansion plans. Deccan is launching a variety of nutraceuticals addressing specific life-style problems and will also explore export opportunities.”
Sandeep Singhal of Nexus Venture Partners said, “The Indian nutraceuticals market is over a billion dollars growing at 30-40% per annum. Mr. Gupta is a passionate entrepreneur who has built Deccan into a leader in the Omega-3 market and is now expanding into a variety of nutritional supplements.”
Manoj Gupta
Subscribe to:
Post Comments (Atom)
The medical market in Indian is showing great success. There has been considerable improve in investing on medical care backed by the increasing buying power of people. Moreover, with a lot of significance being given to preventive medication, the nutraceuticals market in Indian is set to succeed. It is one of the booming markets in Indian.
ReplyDeleteBusiness Profile
This comment has been removed by the author.
ReplyDelete